ARCHIVES

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Guest Editorial By Gregory Reaman: Memories Of A Merger Past

July 15, 2011

Centers Form Big Ten Research Consortium with Access to Over 30,000 New Patients a Year

May 31, 2013

New Jersey Insurers To Cover Patient Care Costs In Trials.

January 14, 2000

In Brief: Cavanee Succeeds Coffey As AACR President; Von Hoff Is President-Elect; Awards Presented

April 10, 1998

Community-Based Program Final Planning Review In August, October

August 6, 1976

Cooperative Group Massacre Hurt Some Of Best CCOPs Which May Go Unfunded

March 27, 1987